Brief: Royalty Pharma Unit Entered Into Amendment No.3 To Amended And Restated Revolving Credit Agreement

Royalty Pharma

27/12/2023 21:57

Dec 27 (Reuters) - Royalty Pharma PLC  RPRX.O :
    * ROYALTY PHARMA  -  ON DEC 22, CO, UNIT ENTERED INTO
AMENDMENT
NO. 3 TO AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT, DATED
AS OF SEPT 15, 2021
    * ROYALTY PHARMA  - THIRD AMENDMENT INCREASES BORROWING
CAPACITY
UNDER CREDIT AGREEMENT FROM $1.5 BILLION TO $1.8 BILLION
    * ROYALTY PHARMA  - REMAINING $110 MILLION OF REVOLVING
COMMITMENTS UNDER CREDIT AGREEMENT MATURES ON OCTOBER 31, 2027

Further company coverage:  RPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))